Effective February 14, 2014, Ferring Canada will transfer the Marketing Rights for Divigel® (DIN: 02377098) to Teva Canada Innovation. Teva Canada Innovation will now manage relationships with healthcare practitioners, community, chain and banner pharmacies, and payers in Canada as they relate to Divigel®.
Newsroom
Friday, 14 February 2014